An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

Item

http://www.wikidata.org/entity/Q24645469

Q24645469

about

Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior Future pharmacological treatments for substance use disorders Addiction science: Uncovering neurobiological complexity Opioid antagonists for alcohol dependence The genetic basis of addictive disorders The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review Topiramate in the treatment of substance-related disorders: a critical review of the literature Alcohol response and consumption in adolescent rhesus macaques: life history and genetic influences Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives Multidisciplinary View of Alcohol Use Disorder: From a Psychiatric Illness to a Major Liver Disease The pharmacology of neurokinin receptors in addiction: prospects for therapy Advances in Medications and Tailoring Treatment for Alcohol Use Disorder Translational behaviour-genetic studies of alcohol: are we there yet?Improving clinical outcomes for naltrexone as a management of problem alcohol use Medications for unhealthy alcohol use: across the spectrum.A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.Neuroimmune basis of methamphetamine toxicity Targeted opioid receptor antagonists in the treatment of alcohol use disorders The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration Chronic ethanol exposure produces tolerance to elevations in neuroactive steroids: mechanisms and reversal by exogenous ACTH Medication treatment of different types of alcoholism.DSM-5 criteria for substance use disorders: recommendations and rationale A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians.Response: anticipating new medications Pharmacogenetics of OPRM1.Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism.Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects.Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys The Genetics, Neurogenetics and Pharmacogenetics of Addiction Consilient research approaches in studying gene x environment interactions in alcohol research.OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample A genetic determinant of the striatal dopamine response to alcohol in men Covariates of craving in actively drinking alcoholics.

P2860

Q22241964-7DF0924D-48B1-4B45-9AED-B0E906AB98FD Q22242633-82A76172-3D24-421C-B5FB-02A4CFC074C2 Q22251251-96F8C234-0AA5-468E-8848-F4CF6AEF4F23 Q24235797-F0A5D74A-EB27-46A5-880A-46AC9A1A962A Q24607129-00C9B3F4-0DD2-4C73-A449-461379278CC8 Q24616528-FE935BDC-6F1E-413B-B550-5D6C97926E7A Q24633145-D6622F79-864B-4B28-BFD5-8F972BA9B892 Q24652359-2F5C8BFB-B7C1-4D59-87BD-0ECD41579E2F Q26746239-A1A17587-04A5-43C4-9315-29615219D88A Q26771090-F2FEAC10-46B6-400E-9648-7E289D4059CF Q26785438-854A52DB-3212-44A5-B0D7-5E398634159A Q26799814-7E80AD0D-7B2C-4051-8AFB-B97E5F667503 Q26860461-0EF85BB4-FD13-485F-AAF3-2C4867E08D1B Q27021406-9E56B73D-2AE5-4D73-B30F-80D15BA2BD8A Q27690692-3D44AD6F-8158-46DC-81C1-47621000C87E Q28068256-74F9ECD1-B98C-4F38-A3DC-8F3D8D15A203 Q28247084-A618DDE2-E7A2-44F1-8DE8-94C8A2C808E2 Q28295125-971A48A7-3FE4-4E29-9F03-10B5935EFCAF Q28483933-EE5D5D2C-506E-475A-AC90-8CA49D870DC5 Q28582398-BF1C20C8-CDF9-4D23-89B5-29665EA99230 Q30434793-F0315AB2-57E8-4469-B2C0-5603BEDBC055 Q30544314-6C8EA9BA-07A1-41C9-8F3C-DDCC6DCF3A92 Q30855550-E4A93968-8068-4182-A47A-C509731D0995 Q33330500-BF9BA4F5-2ECA-4620-B08C-A607876822B2 Q33553146-E1680977-E270-4209-BE91-14ED82038434 Q33568294-DC80E9BA-1D17-4065-9E87-7EF62B62600E Q33591091-80EF0AB8-2400-4E82-8DC0-F3DB40B884D6 Q33643136-9C00698D-FFEC-4A8D-A06F-79EA7E0A975E Q33666303-1B0961BB-B8E2-4323-B268-8701296BA18B Q33740800-9612F24A-6738-4BEC-9324-B7A98FC75F3E Q33746846-2866E069-AD73-4F40-8144-37DA4C3F2EC3 Q33828177-DA6C6AF0-82E6-4373-BE7B-0352D71305DC Q33872457-7164DB20-F99C-44F2-823A-79EA30E4AF30 Q33898930-7BC59B1D-D643-433C-AC56-DBFE60A868FB Q33906915-2F0F2759-8625-4624-A65A-94B21DF0D26D Q33921223-E8BADF8B-30E6-4C13-8815-0601C2BF140B Q33940215-8470A279-A37B-41D8-8FE4-E3BC4644E0EE Q34034252-ED983B26-CC0F-485C-99A7-E102B5AB84AA Q34077390-73A3E5C3-7903-49C4-8921-44D96C02DE71 Q34078217-ACF99356-44E7-4046-8C08-35738772083C

P2860

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

Item

http://www.wikidata.org/entity/Q24645469

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue